Search results for "xbridge"
Results per page
10000 Results Found | Selected Filters:
Time savings using PIPETMAN M96 in an ELISA protocol
This guest editorial from Gilson explores how PIPETMAN® M96 can significantly reduce pipetting time, streamline ELISA workflows, and minimise repetitive strain in the laboratory.
Automated LC-MS/MS brings clinical mass spectrometry closer to routine testing
Roche’s Donald Mason explains how automation, standardization, and core-lab integration could help clinical laboratories expand access to mass spectrometry-based testing
An industry perspective on how AI, automation and connected diagnostics will reshape patient care
Duncan Porter explores the technologies transforming diagnostics, the barriers to adoption and where laboratory leaders should focus their innovation efforts
UK regulator brings new AI and MedTech agenda to the MedTech Conference as it deepens FDA partnership
Alongside AI and international collaboration, the MHRA is progressing wider medical device reform, including improved post-market surveillance and proposed legislative changes to support a more responsive future regulatory framework
Big decisions and rediscovering purpose in medical laboratory science
A specialist scientist’s move from New Zealand to Queensland reveals how choosing personal wellbeing can renew professional purpose and open the door to positive change
KiCqStart Primers and MGB Probe Assays for RT-qPCR
Squid Pipette: one pipette for the full 1-1000 µL range
ELRIG Drug Discovery 2026 conference highlights
dsm-firmenich launches Biond to advance biologics innovation
Specifically designed for cell culture media and biologics manufacturing, Biond™ helps biopharmaceutical companies optimize cell culture performance, improve process consistency, and maximize productivity throughout development and commercial manufacturing
QIAmini: Automated nucleic acid purification
Charles River and Autolomous partner to transform laboratory execution systems
Partnership reinforces continued investment in digitization, automation, and client-facing transparency
De-Risk Early or Pay Later: The power of comprehensive de-risking, from NAMs to beyond
Evotec experts explain why early de-risking is more than avoiding failure, it is about helping the right drug candidates succeed
High RNA quality FFPE Tissue Blocks for biomarker discovery
The high molecular quality of these FFPE tissue samples provides scientists with the highest confidence in derived data quality
























